Role of prostaglandin D2 and CRTH2 blockade in early- and late-phase nasal responses

Clinical and Experimental Allergy

Volumn 44, Issue 8, 2014, Pages 1076-1082

  Shiraishi, Y ^a   Takeda, K ^a   Domenico, J ^a   Gelfand, E W ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

Allergic rhinitis; CRTH2

Indexed keywords

ANTIINFLAMMATORY AGENT; ARRY 063; CHEMOATTRACTANT RECEPTOR HOMOLOGOUS MOLECULE EXPRESSED ON TH2 CELL RECEPTOR; CYTOKINE; OVALBUMIN; PROSTAGLANDIN D2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; ALLERGEN; IMMUNOGLOBULIN RECEPTOR; PROSTAGLANDIN D2 RECEPTOR;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BODY PLETHYSMOGRAPHY; BREATHING RATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG INSTILLATION; DRUG POTENCY; FEMALE; HISTOPATHOLOGY; IMMUNOREACTIVITY; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; NOSE AIRWAY RESISTANCE; NOSE ALLERGY; NOSE OBSTRUCTION; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; SENSITIZATION; TISSUE HOMOGENATE; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DRUG EFFECTS; EOSINOPHIL; IMMUNOLOGY; METABOLISM; NOSE MUCOSA; PATHOLOGY; RHINITIS, ALLERGIC;

ALLERGENS; ANIMALS; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; MICE; NASAL MUCOSA; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; RHINITIS, ALLERGIC;

EID: 84904628164     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12280     Document Type: Article

References (46)

1. Bousquet J, Khaltaev N, Cruz AA et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63:8-160.
2. Wallace DV, Dykewicz MS, Bernstein DI et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008; 122:S1-84.
3. Corrado OJ, Ollier S, Phillips MJ, Thomas JM, Davies RJ. Histamine and allergen induced changes in nasal airways resistance measured by anterior rhinomanometry: reproducibility of the technique and the effect of topically administered antihistaminic and anti-allergic drugs. Br J Clin Pharmacol 1987; 24:283-92.
4. Hata AN, Breyer RM. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 2004; 103:147-66.
5. Luster AD, Tager AM. T-cell trafficking in asthma: lipid mediators grease the way. Nat Rev Immunol 2004; 4:711-24.
6. Luna-Gomes T, Magalhães KG, Mesquita-Santos FP et al. Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation. J Immunol 2011; 187:6518-26.
7. Underwood DC, Muccitelli RM, Luttmann MA, Hay DW, Torphy TJ, Wasserman MA. Differential antagonism of airway contractile responses to prostaglandin (PG)D2 and 9 alpha, 11 beta-PGF2 by atropine, SK&F 88046 and SQ 29, 548 in the guinea pig. J Pharmacol Exp Ther 1994; 268:304-10.
8. Boie Y, Sawyer N, Slipetz DM, Metters KM, Abramovitz M. Molecular cloning and characterization of the human prostanoid DP receptor. J Biol Chem 1995; 270:18910-16.
9. Gervais FG, Cruz RP, Chateauneuf A et al. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J Allergy Clin Immunol 2001; 108:982-8.
10. Hirai H, Tanaka K, Yoshie O et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001; 193:255-61.
11. Hamid-Bloomfield S, Payne AN, Petrovic AA, Whittle BJ. The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C. Br J Pharmacol 1990; 100:761-6.
12. Kim N, Luster AD. Regulation of immune cells by eicosanoid receptors. Scientific World J 2007; 7:1307-28.
13. Schuligoi R, Sturm E, Luschnig P et al. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases. Pharmacology 2010; 85:372-82.
14. Woodward DF, Jones RL, Narumiya S. International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol Rev 2011; 63:471-538.
15. Abe H, Takeshita T, Nagata K et al. Molecular cloning, chromosome mapping and characterization of the mouse CRTH2 gene, a putative member of the leukocyte chemoattractant receptor family. Gene 1999; 227:71-7.
16. Pettipher R. The roles of the prostaglandin D(2) receptors DP(1) and CRTH2 in promoting allergic responses. Br J Pharmacol 2008; 153:S191-9.
17. Hirai H, Tanaka K, Takano S, Ichimasa M, Nakamura M, Nagata K. Cutting edge: agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2. J Immunol 2002; 168:981-5.
18. Matsuoka T, Hirata M, Tanaka H et al. Prostaglandin D2 as a mediator of allergic asthma. Science 2000; 287:2013-17.
19. Hammad H, Kool M, Soullie T et al. Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med 2007; 204:357-67.
20. Philip G, van Adelsberg J, Loeys T et al. Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis. J Allergy Clin Immunol 2009; 124:942-8.
21. Spik I, Brenuchon C, Angeli V et al. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. J Immunol 2005; 174:3703-8.
22. Uller L, Mathiesen JM, Alenmyr L et al. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation. Respir Res 2007; 8:16.
23. Lukacs NW, Berlin AA, Franz-Bacon K et al. CRTH2 antagonism significantly ameliorates airway hyperreactivity and downregulates inflammation-induced genes in a mouse model of airway inflammation. Am J Physiol Lung Cell Molec Physiol 2008; 295:L767-79.
24. Shiraishi Y, Asano K, Niimi K et al. Cyclooxygenase-2/prostaglandin D2/CRTH2 pathway mediates double-stranded RNA-induced enhancement of allergic airway inflammation. J Immunol 2008; 180:541-9.
25. Horak F, Zieglmayer P, Zieglmayer R et al. The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial. Allergy 2012; 67:1572-9.
26. Barnes N, Pavord I, Chuchalin A et al. A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma. Clin Exp Allergy 2012; 42:38-48.
27. Miyahara S, Miyahara N, Takeda K, Joetham A, Gelfand EW. Physiologic assessment of allergic rhinitis in mice: role of the high-affinity IgE receptor (FcepsilonRI). J Allergy Clin Immunol 2005; 116:1020-7.
28. Miyahara S, Miyahara N, Matsubara S, Takeda K, Koya T, Gelfand EW. IL-13 is essential to the late-phase response in allergic rhinitis. J Allergy Clin Immunol 2006; 118:1110-16.
29. Miyahara S, Miyahara N, Lucas JJ et al. Contribution of allergen-specific and nonspecific nasal responses to early-phase and late-phase nasal responses. J Allergy Clin Immunol 2008; 121:718-24.
30. Tomkinson A, Duez C, Cieslewicz G et al. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J Immunol 2001; 166:5792-800.
31. Howarth P. Antihistamines in rhinoconjunctivitis. Clin Allergy Immunol 2002; 17:179-220.
32. Naclerio RM, Meier HL, Kagey-Sobotka A et al. Mediator release after nasal airway challenge with allergen. Am Rev Resp Dis 1983; 128:597-602.
33. Sawyer N, Cauchon E, Chateauneuf A et al. Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br J Pharmacol 2002; 137:1163-72.
34. Nomiya R, Okano M, Fujiwara T et al. CRTH2 plays an essential role in the pathophysiology of Cry j 1-induced pollinosis in mice. J Immunol 2008; 180:5680-8.
35. Suzuki Y, Inoue T, Yamamoto A, Sugimoto Y. Prophylactic effects of the histamine H(1) receptor antagonist epinastine and the dual thromboxane A(2) receptor and chemoattractant receptor-homologous molecule expressed on TH2 cells antagonist ramatroban on allergic rhinitis model in mice. Biol Pharm Bull 2011; 34:507-10.
36. Nagata K, Hirai H, Tanaka K et al. CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett 1999; 59:195-9.
37. Mjösberg JM, Trifari S, Crellin NK et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011; 12:1055-62.
38. Tajima T, Murata T, Aritake K et al. Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2). J Pharmacol Exp Ther 2008; 326:493-501.
39. Heinemann A, Schuligoi R, Sabroe I, Hartnell A, Peskar BA. Delta 12-prostaglandin J2, a plasma metabolite of prostaglandin D2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis. J Immunol 2003; 170:4752-8.
40. Nagata K, Hirai H. The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. Prostaglandins Leukot Essent Fatty Acids 2003; 69:169-77.
41. El-Shazly AE, Begon DY, Kustermans G et al. Novel association between vasoactive intestinal peptide and CRTH2 receptor in recruiting eosinophils: a possible biochemical mechanism forallergic eosinophilic inflammation of the airways. J Biol Chem 2013; 288:1374-84.
42. Schneider E, Thieblemont N, De Moraes M, Dy M. Basophils: new players in the cytokine network. @@Eur Cytokine Network 2010; 21:142-95.
43. Boumiza R, Debard AL, Monneret G. The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy 2005; 3:9.
44. Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJ 2nd. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 1982; 129:1627-31.
45. Holgate ST, Burns GB, Robinson C, Church MK. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. J Immunol 1984; 133:2138-44.
46. 4 receptor and FcεRI in allergic rhinitis. J Immunol 2013; 190:539-48.